FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

373523004: Skin antifungal agent (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1198823011 Skin antifungal agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211991018 Skin antifungal agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1198823011 Skin antifungal agent (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1198823011 Skin antifungal agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211991018 Skin antifungal agent en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1211991018 Skin antifungal agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Skin antifungal agent Is a Local anti-infective false Inferred relationship Existential restriction modifier (core metadata concept)
    Skin antifungal agent Is a Antifungal false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing natamycin in ocular dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Metronidazole+nystatin 400mg/10000units tablet+pessary The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing clioquinol and hydrocortisone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing nystatin and triamcinolone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin + triamcinolone acetonide 100000unt/1mg cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin + triamcinolone acetonide 100000unt/1mg ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin + triamcinolone acetonide 10000unt/1mg ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clioquinol+flumethasone pivalate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Ascorbic acid- and clioquinol-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing metronidazole and nystatin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin+chlorhexidine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin- and tetracycline-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clioquinol + hydrocortisone + pramoxine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin 100,000 units/ml oral suspension sugar free The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasol propionate+neomycin sulfate+Nystatin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide+clioquinol 0.025%/3% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide+clioquinol 0.025%/3% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole nitrate 200mg/2% pessary/2%cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing miconazole and tioconazole (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole 1200mg vaginal insert/miconazole 2.0% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing betamethasone and clioquinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasone butyrate+oxytetracycline+nystatin (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasone butyrate+oxytetracycline+nystatin cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluprednidene- and miconazole-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluprednidene acetate 1 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole nitrate 200mg/sup pessary The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Benzoyl peroxide+miconazole nitrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Miconazole 4% vaginal cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing hydrocortisone and miconazole (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone- and nystatin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Ciclopirox 0.77% topical suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing calamine and clioquinol and zinc oxide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Nystatin-containing product in vaginal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Sodium propionate Is a False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clioquinol Is a False Skin antifungal agent Inferred relationship Existential restriction modifier (core metadata concept)

    Start Page 2 of 2

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    Back to Start